Companies like Pfizer are sitting on a lot of cash right now and with the tax rehaul as a wind in the back of their sails, they just may have a go at it here ? Also PFE Making inroads into generics business...losing Lyrica 2018, should be an interesting year regardless of what happens
Rumor has it the marijuana and bitcoin/blockchain strategy teva has in the works will work out to a huge increase in market cap...